23andMe Faces New Bids Amid Controversy Over Genetic Data Sales
TL;DR Summary
23andMe is holding a second auction for its DNA data with a bid of $305 million from Anne Wojcicki's group, after a legal dispute with Regeneron over the initial auction win. The auction aims to resolve the sale of the company's genetic data amid its bankruptcy due to financial struggles and legal issues.
- 23andMe Sets New Auction With $305 Million New Bid From Ex-CEO Bloomberg
- 23andMe’s Former CEO Pushes Purchase Price Nearly $50 Million Higher WSJ
- 23andMe sold out and sold your genetic info, no consent necessary The Hill
- I worked at 23andMe during its collapse. Here’s what the next consumer-genomics giant needs to understand statnews.com
- 23andMe seeks new bids after $305 million offer from its co-founder Reuters
Reading Insights
Total Reads
0
Unique Readers
0
Time Saved
2 min
vs 3 min read
Condensed
90%
518 → 53 words
Want the full story? Read the original article
Read on Bloomberg